Europe Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

October 2022 | 52 pages | ID: EA897C93F275EN
MarketLine

Abstracts

Europe Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026

SUMMARY

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
• The European biotechnology market had total revenues of $158.2 billion in 2021, representing a compound annual growth rate (CAGR) of 16.6% between 2016 and 2021.
• The medical/healthcare segment generated the most revenue in 2021, with total revenues of $98.0 billion, equivalent to 62% of the market's overall value.
• Italy is the largest market in Europe, accounting for 17.8% of its total value in 2021, followed by German and the UK, which accounted for 17.2% and 13% respectively. As a result, the performance of these markets is reflected in the region as a whole.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts by both value and volume

REASONS TO BUY

• What was the size of the Europe biotechnology market by value in 2021?
• What will be the size of the Europe biotechnology market in 2026?
• What factors are affecting the strength of competition in the Europe biotechnology market?
• How has the market performed over the last five years?
• Who are the top competitors in Europe's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. BioNTech SE
8.4. AstraZeneca PLC
8.5. Bayer AG

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Europe biotechnology industry value: $ billion, 2016–21
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Europe biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Europe biotechnology industry geography segmentation: $ billion, 2021
Table 5: Europe biotechnology industry value forecast: $ billion, 2021–26
Table 6: F. Hoffmann-La Roche Ltd: key facts
Table 7: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 8: F. Hoffmann-La Roche Ltd: Key Employees
Table 9: Novartis AG: key facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: BioNTech SE: key facts
Table 14: BioNTech SE: Annual Financial Ratios
Table 15: BioNTech SE: Key Employees
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: Bayer AG: key facts
Table 20: Bayer AG: Annual Financial Ratios
Table 21: Bayer AG: Key Employees
Table 22: Bayer AG: Key Employees Continued
Table 23: Europe size of population (million), 2017–21
Table 24: Europe gdp (constant 2005 prices, $ billion), 2017–21
Table 25: Europe gdp (current prices, $ billion), 2017–21
Table 26: Europe inflation, 2017–21
Table 27: Europe consumer price index (absolute), 2017–21
Table 28: Europe exchange rate, 2017–21

List Of Figures

LIST OF FIGURES

Figure 1: Europe biotechnology industry value: $ billion, 2016–21
Figure 2: Europe biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Europe biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2021